BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29204064)

  • 1. Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease.
    Nguyen HT; Minar P; Jackson K; Fulkerson PC
    World J Gastroenterol; 2017 Nov; 23(42):7644-7652. PubMed ID: 29204064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Immunosuppressive Therapies for the Treatment of Inflammatory Bowel Disease on Response to Routine Vaccinations: A Meta-Analysis.
    Nguyen DL; Nguyen ET; Bechtold ML
    Dig Dis Sci; 2015 Aug; 60(8):2446-53. PubMed ID: 25796579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.
    Pham HV; Hasan I; Udaltsova N; Pham K; Abramson O; Armstrong MA; Postlethwaite D; Li D
    Dig Dis Sci; 2018 Jan; 63(1):209-217. PubMed ID: 28836068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy.
    Bálint A; Farkas K; Éva PK; Terhes G; Urbán E; Szucs M; Nyári T; Bata Z; Nagy F; Szepes Z; Miheller P; Lorinczy K; Lakatos PL; Lovász B; Tamás S; Kulcsár A; Berényi A; Törocsik D; Daróczi T; Saródi Z; Wittmann T; Molnár T
    Scand J Gastroenterol; 2015 Feb; 50(2):174-81. PubMed ID: 25384624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
    Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL
    Gastroenterology; 2021 Aug; 161(2):669-680.e0. PubMed ID: 33617891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination strategies in pediatric inflammatory bowel disease.
    Dipasquale V; Romano C
    Vaccine; 2017 Oct; 35(45):6070-6075. PubMed ID: 28967524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.
    Lawrance IC; Radford-Smith GL; Bampton PA; Andrews JM; Tan PK; Croft A; Gearry RB; Florin TH
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1732-8. PubMed ID: 21039834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
    Jones JL; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Benchimol EI
    Gastroenterology; 2021 Aug; 161(2):681-700. PubMed ID: 34334167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review.
    Agarwal N; Ollington K; Kaneshiro M; Frenck R; Melmed GY
    Vaccine; 2012 Feb; 30(8):1413-24. PubMed ID: 22197580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3).
    Loras C; Gisbert JP; Saro MC; Piqueras M; Sánchez-Montes C; Barrio J; Ordás I; Montserrat A; Ferreiro R; Zabana Y; Chaparro M; Fernández-Bañares F; Esteve M;
    J Crohns Colitis; 2014 Nov; 8(11):1529-38. PubMed ID: 25052345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease.
    Melmed GY; Agarwal N; Frenck RW; Ippoliti AF; Ibanez P; Papadakis KA; Simpson P; Barolet-Garcia C; Ward J; Targan SR; Vasiliauskas EA
    Am J Gastroenterol; 2010 Jan; 105(1):148-54. PubMed ID: 19755964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the vaccination in inflammatory bowel disease.
    Carrera E; Manzano R; Garrido E
    World J Gastroenterol; 2013 Mar; 19(9):1349-53. PubMed ID: 23538553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
    Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL
    J Can Assoc Gastroenterol; 2021 Aug; 4(4):e59-e71. PubMed ID: 34476338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients.
    Caldera F; Saha S; Wald A; Garmoe CA; McCrone S; Megna B; Ley D; Reichelderfer M; Hayney MS
    Dig Dis Sci; 2018 Jun; 63(6):1532-1540. PubMed ID: 29594970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.
    Kopylov U; Levin A; Mendelson E; Dovrat S; Book M; Eliakim R; Ben-Horin S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):145-50. PubMed ID: 22612376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients.
    Müller KE; Dohos D; Sipos Z; Kiss S; Dembrovszky F; Kovács N; Solymár M; Erőss B; Hegyi P; Sarlós P
    Vaccine; 2022 Mar; 40(13):2076-2086. PubMed ID: 35227523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insufficient awareness and vaccination practices for inflammatory bowel disease patients in China: A multi-center survey of Chinese gastroenterologists.
    Li SY; Li PW; Shen B; Zhi M; Gu YB; Wang XY; Guo H; Li Y; Fan YH; Yang BL; Xue M; Wang XY; Lv MF; Li Y; Ye B; Zhu XJ; Chen Y
    J Dig Dis; 2020 Jan; 21(1):46-51. PubMed ID: 31794121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease.
    Urganci N; Kalyoncu D
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):412-15. PubMed ID: 23841120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.